Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. As the pharmaceutical industry continues to expand and new drugs enter the market, the importance of robust pharmacovigilance systems has never been greater, driving significant growth in the Pharmacovigilance PV Market. Pharmacovigilance is not merely a regulatory requirement—it is a critical component of patient safety and public health. By systematically monitoring the safety of medicines throughout their lifecycle, pharmacovigilance helps identify previously unknown adverse effects, assess risk-benefit profiles, and implement risk mitigation strategies that protect patients.

The Pharmacovigilance PV Market was valued at approximately USD 7.9 billion in 2024 and is projected to reach USD 13.49 billion by 2035, growing at a CAGR of 4.98%. This growth is driven by stringent regulatory requirements, the rising incidence of adverse drug reactions (ADRs), and the increasing complexity of drug development. Pharmacovigilance services encompass a range of activities, including adverse event reporting, signal detection, risk management, and regulatory compliance. As pharmaceutical companies expand their portfolios and enter new markets, the demand for comprehensive pharmacovigilance services continues to grow, creating opportunities for both established providers and new entrants.

Technological advancements are transforming pharmacovigilance practices. The integration of artificial intelligence and machine learning is enabling more efficient data analysis and signal detection, while cloud-based solutions are improving data accessibility and collaboration. AI-powered systems can process vast volumes of safety data, identify patterns and signals more quickly, and reduce the burden of manual case processing. Additionally, the growing emphasis on patient-centric approaches is driving demand for pharmacovigilance systems that incorporate patient feedback and real-world evidence. Patients are increasingly recognised as important sources of safety information, and their contributions can complement traditional reporting channels. As healthcare systems worldwide continue to prioritise drug safety, the Pharmacovigilance PV Market is well-positioned for sustained growth. Providers that invest in advanced technologies, regulatory expertise, and patient-centred approaches will be best positioned to capture emerging opportunities.

People Also Ask

• What is pharmacovigilance?
  Pharmacovigilance is the science of detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems.

• Why is pharmacovigilance important?
  Pharmacovigilance is essential for ensuring drug safety, protecting patients from adverse effects, and maintaining regulatory compliance.

Tags: #Pharmacovigilance #DrugSafety #AdverseEventReporting #PatientSafety #Pharmaceuticals #RegulatoryCompliance